The products are far from a proven sleep treatment.
A new randomized clinical trial from investigators at Mass General Brigham’s Neuroscience Institute and Department of ...
Postbiotics are gaining momentum. How can ingredient branding support the accessibility of postbiotics in F&B applications?
US Health and Human Services Secretary Robert F. Kennedy Jr. attacks scientific literature with censorship to push MAHA ...
Morning Overview on MSNOpinion
A once-a-day pill nearly doubled survival for patients with advanced pancreatic cancer in a 500-person trial
Patients with previously treated metastatic pancreatic cancer lived roughly twice as long when given an oral pill called ...
A new randomized clinical trial from investigators at Mass General Brigham's Neuroscience Institute and Department of ...
Morning Overview on MSN
An experimental drug doubled one-year survival for pancreatic cancer patients
Patients with metastatic pancreatic cancer who received the experimental drug elraglusib alongside standard chemotherapy saw ...
In two analyses, Noom members were modeled to gain less than 2% of bodyweight up to 12 months after stopping medication — ...
After a four-month investigation, Nature Medicine has decided to pull a viral study that linked early-day PD-1/chemo ...
A new randomized clinical trial from investigators at Mass General Brigham's Neuroscience Institute and Department of Psychiatry suggests that using personalized brain imaging to guide transcranial ...
SCOTTSDALE, Ariz., June 10, 2026 (GLOBE NEWSWIRE) -- Applied Biologics, a biopharmaceutical company advancing novel biologic therapies for chronic wounds, tissue repair, and degenerative disease, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results